Global Canine Flu Therapeutics Industry suggests it will attain US … – PharmiWeb.com

Canine Flu Therapeutics Industry

The global canine flu therapeutics industry is expected to grow at a CAGR of 4.1% from 2023 to 2033, reaching a value of US$ 3.06 billion by 2033, while the market is likely to reach a value of US$ 2.04 billion in 2023. The market is driven by a number of factors, including the rising prevalence of canine flu, increasing pet humanization, and growing awareness of the importance of canine healthcare.

Canine flu is a highly contagious respiratory illness caused by influenza A viruses. It is transmitted through direct contact with an infected dog or through respiratory droplets. The virus can also survive on surfaces for up to 48 hours, making it easy for dogs to become infected.

Discover Our Expert Analysis with Our Sample Report! https://www.futuremarketinsights.com/reports/sample/rep-gb-4315

Symptoms of canine flu can include fever, cough, runny nose, lethargy, and loss of appetite. In severe cases, the virus can cause pneumonia and death. Most dogs recover from canine flu within two to three weeks, but some may develop chronic lung problems.

There is no specific treatment for canine flu. Treatment is typically supportive and includes rest, fluids, and medications to relieve symptoms. Antibiotics may be prescribed to prevent secondary bacterial infections.

The canine flu therapeutics market is expected to grow steadily in the coming years. This growth is being driven by a number of factors, including:

Key Takeaways:

Reach Out To Our Analyst For Prompt Assistance With Your Questions! https://www.futuremarketinsights.com/ask-question/rep-gb-4315

Key players in the canine flu therapeutics market include:

Key Segments Covered:

By Drug Class:

By Distribution Channel:

Key Regions Covered:

Elevate Your Brand: Explore the Insights from Our Customization Report! https://www.futuremarketinsights.com/customization-available/rep-gb-4315

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Nandini Singh Sawlani

Future Market Insights Inc. Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware 19713, USA T: +1-845-579-5705 For Sales Enquiries:sales@futuremarketinsights.com Website:https://www.futuremarketinsights.com LinkedIn|Twitter|Blogs | YouTube

Go here to see the original:

Global Canine Flu Therapeutics Industry suggests it will attain US ... - PharmiWeb.com